De novo malignancies after liver transplantation: epidemiology, risk factors, and management strategies

Read full text Summarise with VIRAT
Authors: Константин Олесьевич Сёмаш, Timur Dzhanbekov, Mansur Nasirov, Q. M. Umarov, A. B. Khudaybergenova
Cited by: 0
References: 141

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background. Liver transplantation (LT) significantly improves survival in patients with end-stage liver disease; however, it is associated with an increased risk of developing de novo malignancies. Long-term immunosuppression, viral infections, and unhealthy lifestyle choices increase the risk of post-transplant oncological complications. Objective: to summarize current evidence on the prevalence, risk factors, diagnostic, prevention, and treatment of de novo malignancies in liver transplant recipients. Materials and methods. This paper presents a literature review, including retrospective and prospective studies, meta-analyses, and clinical guidelines published over the past two decades. Results. The most common post-transplant malignancies include non-melanoma skin cancer, lymphoproliferative disorders, and solid organ tumors. Major risk factors are prolonged immunosuppression, viral infections, smoking, alcohol use, advanced recipient age, and the underlying liver disease. Current management strategies involve immunosuppression reduction, surgical resection, chemotherapy, and targeted therapy. In particular, mammalian target of rapamycin (mTOR) inhibitors have demonstrated antitumor efficacy in selected patients, particularly those with Kaposi’s sarcoma and lymphoproliferative disorders. Conclusion. Given the high oncological risk, stratified screening programs and individualized patient management are necessary after LT. Immunosuppression reduction, lifestyle modification, and early detection of malignancies are key factors in improving long-term outcomes.

Fields of Study & Subjects

Organ Transplantation Techniques and Outcomes Viral-associated cancers and disorders Hepatocellular Carcinoma Treatment and Prognosis

Publication details

Journal / source
Russian Journal of Transplantology and Artificial Organs
Volume
28
Issue
1
Pages
47–63
Publication date
31 March 2026
Language
EN